A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?

被引：0
|
作者：
M. Mitroiu
K. Oude Rengerink
S. Teerenstra
F. Pétavy
K. C. B. Roes
机构：
[1] College ter Beoordeling van Geneesmiddelen,Methodology Working Group
[2] University of Utrecht,Department of Biostatistics and Research Support, Clinical Trial Methodology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
[3] Radboud University Medical Center,Department for Health Evidence, Section Biostatistics, Radboud Institute for Health Sciences
[4] European Medicines Agency,Biostatistics and Methodology Support Office
来源：
Trials | / 21卷
关键词：
Estimand; Intention-to-treat; Per protocol; Intercurrent event; Post-randomisation event; Study withdrawal; Treatment compliance; Treatment adherence; Treatment discontinuation; Missing data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Old and New Biomarkers of Alcohol Abuse: Narrative Review
    Fakhari, Sara
    Waszkiewicz, Napoleon
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [22] NGOs, corporate social responsibility and sustainable development trajectories in a new reformative spectrum: 'New wine in old bottles or old wine in new bottles?'
    Esposito, Paolo
    Antonucci, Gianluca
    [J]. CORPORATE SOCIAL RESPONSIBILITY AND ENVIRONMENTAL MANAGEMENT, 2022, 29 (03) : 609 - 619
  • [23] New regulatory framework for cancer drug development
    Jones, Paul S.
    Jones, David
    [J]. DRUG DISCOVERY TODAY, 2012, 17 (5-6) : 227 - 231
  • [24] The New Stealth Drug on the Street: A Narrative Review of Xylazine as a Street Drug
    Pergolizzi Jr, Joseph
    LeQuang, Jo Ann K.
    Magnusson, Peter
    Miller, Thomas L.
    Breve, Frank
    Varrassi, Giustino
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [25] Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review
    Mitra, Amitava
    Wang, Yaning
    [J]. PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1663 - 1667
  • [26] Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review
    Amitava Mitra
    Yaning Wang
    [J]. Pharmaceutical Research, 2022, 39 : 1663 - 1667
  • [27] SCIENTIFIC AND REGULATORY PERSPECTIVES ON DRUG INTERACTION EVALUATION DURING DRUG DEVELOPMENT
    Zhang, Lei
    [J]. DRUG METABOLISM REVIEWS, 2014, 45 : 18 - 18
  • [28] The Utility of Modeling and Simulation in Drug Development and Regulatory Review
    Huang, Shiew-Mei
    Abernethy, Darrell R.
    Wang, Yaning
    Zhao, Ping
    Zineh, Issam
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (09) : 2912 - 2923
  • [29] Drug Development Old drugs, new tricks
    Shaughnessy, Allen F.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [30] Novel formulations of taxanes: a review. Old wine in a new bottle?
    Hennenfent, KL
    Govindan, R
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (05) : 735 - 749
12345